This is an aggregated industry headline. Read the full story at PharmaVoice →
Novo talks up drug launches in effort to win back investors
At a "capital markets day" in London, executives outlined a roadmap to better compete with key rival Eli Lilly and soon bring forth several multibillion-dollar products.
By PharmaVoice
· Sep 23, 2026
· via PharmaVoice
RxInsider combines reported facts with industry analysis and informed inference. Forward-looking reads, market commentary, and interpretive framing reflect analysis of available reporting and known facts, not confirmed outcomes.
Tags
theweekformat:headlineheadlinePharmaVoice
The Insider - Weekly pharma intelligence
Deals, negotiations, and policy analysis. Delivered when it matters.
No sponsored content. No noise. Unsubscribe anytime.
More from The Week
All The Week →
The WeekBriefing
AJMC reported that Medicare drug price negotiations are yielding uneven out-of-pocket savings. The policy sign…
The WeekPharmaceutical Technology ↗
China's NMPA has approved the MAA for Foresee Pharmaceuticals' Camcevi 42 mg to treat adult patients with adva…
The WeekKFF Health News ↗
Health care's AI future is being built right now. The open question is "for whom?" Dr. Uché Blackstock - emerg…